HomeAI · summaries
Storia in 2 fonti
TwinStrand wins patent case; GSK’s hepatitis B drug approved in Japan
TwinStrand beats Guardant Health in patent case, wins $245.2M. GSK's hepatitis B drug bepirovirsen (Hibsago) approved in Japan, under US review. Erasca gets FDA fast-track for pancreatic cancer look-alike.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University…
TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University of Washington More Than $245.2 Million…
- ·
endpoints.news
TwinStrand wins patent case; GSK’s hepatitis B drug approved in Japan
TwinStrand beats Guardant Health in patent case, wins $245.2M. GSK's hepatitis B drug bepirovirsen (Hibsago) approved in Japan, under US review. Erasca gets FDA fast-track for…